14岁男孩的儿科肝细胞癌:一个罕见的病例报告
Jyoti Rajpoot1, Manjula Jain1, Mukta Pujani1
1Department of Pathology, ESIC Medical College, Faridabad, Haryana, India.
Journal of cancer research and therapeutics
|October 16, 2024
概括
肝细胞癌 (HCC) 在儿童中很少见,但乙型肝炎病毒 (HBV) 感染会增加风险. 这一案例突出了HBV阳性儿科HCC的呈现和诊断.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 儿科瘤学 儿科瘤学
- 病毒瘤学 病毒瘤学
背景情况:
- 肝细胞癌 (HCC) 在儿童群体中相比成年人少得多,每年发生率为每百万0.7例.
- 乙型肝炎病毒 (HBV) 是已知的致癌物,增加了HCC的风险,特别是在年轻时.
- 在HBV阳性男性儿童中发表的HCC病例报告很少.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...


